Fructose-1,6-bisphosphatase 1 functions as a protein phosphatase to dephosphorylate histone H3 and suppresses PPARα-regulated gene transcription and tumour growth
Zheng Wang,Min Li,Hongfei Jiang,Shudi Luo,Fei Shao,Yan Xia,Mengke Yang,Xiangle Ren,Tong Liu,Meisi Yan,Xu Qian,Haiyan He,Dong Guo,Yuran Duan,Ke Wu,Lei Wang,Guimei Ji,Yuli Shen,Lin Li,Peixiang Zheng,Bofei Dong,Jing Fang,Min Zheng,Tingbo Liang,Haitao Li,Rilei Yu,Daqian Xu,Zhimin Lu
DOI: https://doi.org/10.1038/s41556-022-01009-4
Abstract:Tumour cells exhibit greater metabolic plasticity than normal cells and possess selective advantages for survival and proliferation with unclearly defined mechanisms. Here we demonstrate that glucose deprivation in normal hepatocytes induces PERK-mediated fructose-1,6-bisphosphatase 1 (FBP1) S170 phosphorylation, which converts the FBP1 tetramer to monomers and exposes its nuclear localization signal for nuclear translocation. Importantly, nuclear FBP1 binds PPARα and functions as a protein phosphatase that dephosphorylates histone H3T11 and suppresses PPARα-mediated β-oxidation gene expression. In contrast, FBP1 S124 is O-GlcNAcylated by overexpressed O-linked N-acetylglucosamine transferase in hepatocellular carcinoma cells, leading to inhibition of FBP1 S170 phosphorylation and enhancement of β-oxidation for tumour growth. In addition, FBP1 S170 phosphorylation inversely correlates with β-oxidation gene expression in hepatocellular carcinoma specimens and patient survival duration. These findings highlight the differential role of FBP1 in gene regulation in normal and tumour cells through direct chromatin modulation and underscore the inactivation of its protein phosphatase function in tumour growth.